HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology G
about
Advanced oropharyngeal squamous cell carcinoma: Pathogenesis, treatment, and novel therapeutic approachesRecent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerManagement of Oropharyngeal Cancer in the HPV Era.DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.HPV and beyond-looking out for biomarkers for distinguishing the good prognosis from the bad prognosis group in locally advanced and clinically high risk HNSCCIncrease in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy.Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.Epigenetics of oropharyngeal squamous cell carcinoma: opportunities for novel chemotherapeutic targets.PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinomaThe PD-1/PD-L1 axis and human papilloma virus in patients with head and neck cancer after adjuvant chemoradiotherapy: A multicentre study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis.Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.Human papillomavirus confers radiosensitivity in cancer cervix: a hypothesis toward a possible restoration of apoptotic pathways based on clinical outcomes.The changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94).CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy.Heat shock protein 70 and tumor-infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation OncoloSDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.The clinical target volume in lung, head-and-neck, and esophageal cancer: Lessons from pathological measurement and recurrence analysis.Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy.Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".De-intensification of adjuvant therapy in human papillomavirus-associated oropharyngeal cancerEpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
P2860
Q26767046-746A311E-95EC-4805-A2FD-3618E612AE00Q26782255-F273695D-2633-47E6-B2C5-95EBD91520D9Q30248326-2CB2F369-6E61-46E1-A4EF-EB79018873DFQ36073749-6C6CF564-4A41-4CC8-90E6-8FB0320EC6D9Q36204937-40540E39-9E86-4944-A8E0-068B9ABDE180Q36300626-18BD8F72-B9EA-409F-810A-30E462F5C532Q36544134-F1D046B6-F38A-4BB0-A986-846451266211Q37615798-8E70CAE4-AEA7-43ED-BE83-72399758A5EFQ37689028-749DEF92-3890-4EC8-A94D-3F5B60BB298AQ38686682-88A97BE9-1A8E-47DE-BA2D-7752BF195D56Q38755736-A718FCB0-0C0A-4ABB-88FD-C117DB8ACB6DQ38763503-ED113595-00E9-4E10-AB6A-E355757780BBQ38890716-11220810-14DA-4F68-86A6-7B967821A0A5Q39009682-D609838E-CB34-42AC-965A-DB25243B87C2Q39037647-BB8AFBEE-8AB9-4E6F-9A12-7A2F2022127BQ39669627-1F18A171-D21B-40EE-89BA-F3570D1F8F2BQ40732246-ACBD36BF-37F6-4217-A12E-050B0BAADE89Q40858416-E13EE93C-ED6A-4E29-96C3-48D3037A5399Q47299395-D04BEF53-D2C3-43F3-8522-DB3662196641Q52624081-6584C6A1-34E9-433E-879E-B51C07D5BD39Q55398529-D68585E7-661A-41E6-83E2-FB597ACF6789Q55416865-B16BC44B-3099-43D2-AD3A-42C977D3E7E9Q55517753-C340E285-6C3F-4A12-9026-9E7627C723CAQ56532865-1227BB35-8B1E-4177-AD84-1ADDA8560CABQ59127611-E603B757-84F7-4C85-9E54-63F94AC01C7E
P2860
HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology G
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@en
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@nl
type
label
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@en
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@nl
prefLabel
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@en
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@nl
P2093
P50
P1476
HPV16 DNA status is a strong p ...... onsortium Radiation Oncology G
@en
P2093
Amir Abdollahi
Anca-Ligia Grosu
Annett Linge
Christine Bayer
Claus Belka
Claus Rödel
David Mönnich
Eleni Gkika
Gustavo B Baretton
P304
P356
10.1016/J.RADONC.2014.11.011
P50
P577
2014-12-02T00:00:00Z